What is NDC 0781-2321?

0781-2321 is the product NDC for Aprepitant, Aprepitant 40 mg/1 capsule, listed with the FDA by Sandoz Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.

Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aprepitant?

19 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aprepitant NDC 0781-2321 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-2321Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-2321Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0781-2321-06	00781232106	1 BLISTER PACK in 1 CARTON (0781-2321-06) / 1 CAPSULE in 1 BLISTER PACKMarketed from Dec 27, 2016
0781-2321-51	00781232151	5 BLISTER PACK in 1 CARTON (0781-2321-51) / 1 CAPSULE in 1 BLISTER PACKMarketed from Dec 27, 2016

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aprepitant
Generic name (nonproprietary): aprepitant
Active ingredients: Aprepitant — 40 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Sandoz IncNDC labeler code 0781
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090999
Marketing start: Dec 27, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
Identifiers: Product ID 0781-2321_a194823e-5961-4bc0-b18f-2f63d3cbb9c6SPL ID a194823e-5961-4bc0-b18f-2f63d3cbb9c6SPL set ID f58b8944-93ee-4be1-a238-cc0061ddd93aRxCUI 403810, 403811, 644088, 754508UNII 1NF15YR6UY
Pharmacologic class: Substance P/Neurokinin-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400781232106 followed by a unit qualifier and the quantity

Package 00781-2321-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 9, 2024.

Indications (excerpt from the label)

Aprepitant is a substance P/neurokinin 1 (NK 1 ) receptor antagonist. Aprepitant capsules is indicated • in combination with other antiemetic agents, in patients 12 years of age and older for prevention of: • acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin ( 1.1 ) • nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC) ( 1.1 ) • for prevention of postoperative nausea and vomiting (PONV) in adults ( 1.2 ) Limitations of Use ( 1.3 ) • Aprepitant capsules have not been studied for treatment of established nausea and vomiting. •…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0781-2321

What is NDC 0781-2321?: 0781-2321 is the product NDC for Aprepitant, Aprepitant 40 mg/1 capsule, listed with the FDA by Sandoz Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aprepitant.
What is the active ingredient?: Aprepitant.
Who is the labeler?: Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aprepitant?: 19 other product NDCs are listed under this name. See all Aprepitant NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Aprepitant NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	BluePoint Laboratories	68001-668	68001-0668-19
Aprepitant	—	Kit	BluePoint Laboratories	68001-669	68001-0669-15
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	BluePoint Laboratories	68001-666	68001-0666-0168001-0666-17
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	BluePoint Laboratories	68001-667	68001-0667-0168001-0667-19
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-591	13668-0591-8113668-0591-82
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-592	13668-0592-8413668-0592-86
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-593	13668-0593-86
Aprepitant	—	Kit	Torrent Pharmaceuticals Limited	13668-594	13668-0594-87
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-701	51407-0701-0151407-0701-05
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-702	51407-0702-0251407-0702-06

All 20 Aprepitant NDCs

Other NDCs under ANDA 090999

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090999
Product	Strength	Form · route	Labeler	Product NDC
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Sandoz Inc	0781-2322
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Sandoz Inc	0781-2323
Aprepitant	—	Kit	Sandoz Inc	0781-4063